Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zenas BioPharma, Inc. ("Zenas BioPharma" or the "Company") (NASDAQ: ZBIO) investors of a class action representing investors that bought securities pursuant and/or traceable to Zenas BioPharma’s registration statement issued in connection with its initial public offering (“IPO”) held on or around September 13, 2024, and suffered damages as a re ...